Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 253, Issue 9, 2015, Pages 1503-1513

  Fu, Zhongjie ^a   Nian, Shen ^a   Li, Suk Yee ^a   Wong, David ^a   Chung, Sookja K ^a   Lo, Amy C Y ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Hong Kong Jockey Club Building for Interdisciplinary Research ^*  (Hong Kong)

Author keywords

Aldose reductase; Oxygen induced retinopathy; Retinal neurons; Retinopathy of prematurity

Indexed keywords

ALDEHYDE REDUCTASE; CALBINDIN; CALRETININ; GLIAL FIBRILLARY ACIDIC PROTEIN; OXYGEN; PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN TUJ1; UNCLASSIFIED DRUG; BETA3 TUBULIN, MOUSE; CALB2 PROTEIN, MOUSE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; NERVE PROTEIN; TUBULIN;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CONTROLLED STUDY; CYTOARCHITECTURE; ELECTRORETINOGRAPHY; GENE DELETION; GLIOSIS; HISTOPATHOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; MOUSE; MOUSE MODEL; MUELLER CELL; NEWBORN; NONHUMAN; OSCILLATORY POTENTIAL; OXYGEN-INDUCED RETINOPATHY; PERINATAL PERIOD; PRIORITY JOURNAL; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA HORIZONTAL NERVE CELL; RETINA INNER NUCLEAR LAYER; RETINA INNER PLEXIFORM LAYER; RETINA NERVE CELL; RETINA OUTER NUCLEAR LAYER; RETINA ROD; RETINAL NERVE FIBER LAYER THICKNESS; RETROLENTAL FIBROPLASIA; WILD TYPE; ANIMAL; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; RETINA; RETINOPATHY OF PREMATURITY;

ALDEHYDE REDUCTASE; ANIMALS; ANIMALS, NEWBORN; CALBINDIN 2; CALBINDINS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; GLIOSIS; IMMUNOHISTOCHEMISTRY; MICE; NERVE TISSUE PROTEINS; PROTEIN KINASE C-ALPHA; RETINA; RETINAL NEURONS; RETINOPATHY OF PREMATURITY; TUBULIN;

EID: 84940436877     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-015-3024-0     Document Type: Article

References (61)

1. Terry TL (1942) Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects. Trans Am Ophthalmol Soc 40:262–284
2. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B (2005) The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116:15–23. doi:10.1542/peds.2004-1413
3. Narayanan SP, Suwanpradid J, Saul A, Xu Z, Still A, Caldwell RW, Caldwell RB (2011) Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity. PLoS ONE 6:e22460. doi:10.1371/journal.pone.0022460
4. Vessey KA, Wilkinson-Berka JL, Fletcher EL (2011) Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy. J Comp Neurol 519:506–527. doi:10.1002/cne.22530
5. Fletcher EL, Downie LE, Hatzopoulos K, Vessey KA, Ward MM, Chow CL, Pianta MJ, Vingrys AJ, Kalloniatis M, Wilkinson-Berka JL (2010) The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy. Doc Ophthalmol 120:67–86. doi:10.1007/s10633-009-9193-6
6. O’Connor AR, Stephenson T, Johnson A, Tobin MJ, Moseley MJ, Ratib S, Ng Y, Fielder AR (2002) Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. Pediatrics 109:12–18
7. Fulton AB, Hansen RM (1996) Photoreceptor function in infants and children with a history of mild retinopathy of prematurity. J Opt Soc Am A Opt Image Sci Vis 13:566–571
8. Hansen RM, Harris ME, Moskowitz A, Fulton AB (2010) Deactivation of the rod response in retinopathy of prematurity. Doc Ophthalmol 121:29–35. doi:10.1007/s10633-010-9228-z
9. Harris ME, Moskowitz A, Fulton AB, Hansen RM (2011) Long-term effects of retinopathy of prematurity (ROP) on rod and rod-driven function. Doc Ophthalmol 122:19–27. doi:10.1007/s10633-010-9251-0
10. Fulton AB, Hansen RM, Moskowitz A (2009) Development of rod function in term born and former preterm subjects. Optom Vis Sci 86:E653–E658. doi:10.1097/OPX.0b013e3181a6a237
11. Fulton AB, Hansen RM, Moskowitz A, Barnaby AM (2005) Multifocal ERG in subjects with a history of retinopathy of prematurity. Doc Ophthalmol 111:7–13. doi:10.1007/s10633-005-2621-3
12. Liang X, Zhou H, Ding Y, Li J, Yang C, Luo Y, Li S, Sun G, Liao X, Min W (2012) TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model. Invest Ophthalmol Vis Sci 53:2157–2169. doi:10.1167/iovs.11-9315
13. Liu K, Akula JD, Falk C, Hansen RM, Fulton AB (2006) The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 47:2639–2647. doi:10.1167/iovs.06-0016
14. Reynaud X, Hansen RM, Fulton AB (1995) Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest Ophthalmol Vis Sci 36:2071–2079
15. Chen J, Stahl A, Hellstrom A, Smith LE (2011) Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr 23:173–178. doi:10.1097/MOP.0b013e3283423f35
16. Clark D, Mandal K (2008) Treatment of retinopathy of prematurity. Early Hum Dev 84:95–99. doi:10.1016/j.earlhumdev.2007.11.007
17. Harder BC, von Baltz S, Jonas JB, Schlichtenbrede FC (2011) Intravitreal bevacizumab for retinopathy of prematurity. J Ocul Pharmacol Ther 27:623–627. doi:10.1089/jop.2011.0060
18. Davis JM, Auten RL (2010) Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 15:191–195. doi:10.1016/j.siny.2010.04.001
19. Quinn GE, Johnson L, Otis C, Schaffer DB, Bowen FW (1990) Incidence, severity and time course of ROP in a randomized clinical trial of vitamin E prophylaxis. Doc Ophthalmol 74:223–228
20. Cheung AK, Lo AC, So KF, Chung SS, Chung SK (2007) Gene deletion and pharmacological inhibition of aldose reductase protect against retinal ischemic injury. Exp Eye Res 85:608–616. doi:10.1016/j.exer.2007.07.013
21. Chung SS, Ho EC, Lam KS, Chung SK (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233–S236
22. Lee AY, Chung SS (1999) Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 13:23–30
23. Lou MF, Dickerson JE Jr, Garadi R, York BM Jr (1988) Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res 46:517–530
24. Obrosova IG (2005) Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal 7:1543–1552. doi:10.1089/ars.2005.7.1543
25. Obrosova IG, Pacher P, Szabo C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA (2005) Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54:234–242
26. Song Z, Fu DT, Chan YS, Leung S, Chung SS, Chung SK (2003) Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress. Mol Cell Neurosci 23:638–647
27. Fu ZJ, Li SY, Kociok N, Wong D, Chung SK, Lo AC (2012) Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 53:5698–5712. doi:10.1167/iovs.12-10122
28. Ho HT, Chung SK, Law JW, Ko BC, Tam SC, Brooks HL, Knepper MA, Chung SS (2000) Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Mol Cell Biol 20:5840–5846
29. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D’Amato R, Sullivan R, D’Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101–111
30. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4:1565–1573. doi:10.1038/nprot.2009.187
31. Akula JD, Mocko JA, Moskowitz A, Hansen RM, Fulton AB (2007) The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci 48:5788–5797. doi:10.1167/iovs.07-0881
32. Li SY, Yang D, Fu ZJ, Woo T, Wong D, Lo AC (2012) Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke. Neurobiol Dis 45:624–632. doi:10.1016/j.nbd.2011.10.008
33. Yang D, Li SY, Yeung CM, Chang RC, So KF, Wong D, Lo AC (2012) Lycium barbarum extracts protect the brain from blood–brain barrier disruption and cerebral edema in experimental stroke. PLoS ONE 7, e33596. doi:10.1371/journal.pone.0033596
34. Haverkamp S, Wassle H (2000) Immunocytochemical analysis of the mouse retina. J Comp Neurol 424:1–23
35. Li SY, Fu ZJ, Ma H, Jang WC, So KF, Wong D, Lo AC (2009) Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Invest Ophthalmol Vis Sci 50:836–843. doi:10.1167/iovs.08-2310
36. Morrow EM, Chen CM, Cepko CL (2008) Temporal order of bipolar cell genesis in the neural retina. Neural Dev 3:2. doi:10.1186/1749-8104-3-2
37. Robinson GA, Madison RD (2004) Axotomized mouse retinal ganglion cells containing melanopsin show enhanced survival, but not enhanced axon regrowth into a peripheral nerve graft. Vis Res 44:2667–2674. doi:10.1016/j.visres.2004.06.010
38. Watanabe M, Rutishauser U, Silver J (1991) Formation of the retinal ganglion cell and optic fiber layers. J Neurobiol 22:85–96. doi:10.1002/neu.480220109
39. Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50:427–434. doi:10.1002/glia.20207
40. Miller RF, Dowling JE (1970) Intracellular responses of the Muller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram. J Neurophysiol 33:323–341
41. Nakamura S, Imai S, Ogishima H, Tsuruma K, Shimazawa M, Hara H (2012) Morphological and functional changes in the retina after chronic oxygen-induced retinopathy. PLoS ONE 7:e32167. doi:10.1371/journal.pone.0032167
42. Dal Monte M, Latina V, Cupisti E, Bagnoli P (2012) Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. Naunyn Schmiedeberg’s Arch Pharmacol 385:481–494. doi:10.1007/s00210-012-0735-1
43. Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17:485–521
44. Mowat FM, Gonzalez F, Luhmann UF, Lange CA, Duran Y, Smith AJ, Maxwell PH, Ali RR, Bainbridge JW (2012) Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy. Am J Pathol 180:1726–1739. doi:10.1016/j.ajpath.2011.12.033
45. Fulton AB, Reynaud X, Hansen RM, Lemere CA, Parker C, Williams TP (1999) Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci 40:168–174
46. Dembinska O, Rojas LM, Varma DR, Chemtob S, Lachapelle P (2001) Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats. Invest Ophthalmol Vis Sci 42:1111–1118
47. Olney JW (1968) An electron microscopic study of synapse formation, receptor outer segment development, and other aspects of developing mouse retina. Invest Ophthalmol 7:250–268
48. Bai Y, Ma JX, Guo J, Wang J, Zhu M, Chen Y, Le YZ (2009) Müller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol 219:446–454. doi:10.1002/path.2611
49. Dorrell MI, Aguilar E, Jacobson R, Trauger SA, Friedlander J, Siuzdak G, Friedlander M (2010) Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia 58:43–54. doi:10.1002/glia.20900
50. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A (2006) Müller cells in the healthy and diseased retina. Prog Retin Eye Res 25:397–424. doi:10.1016/j.preteyeres.2006.05.003
51. Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, Wiedemann P, Osborne NN, Reichenbach A (2009) Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 28:423–451. doi:10.1016/j.preteyeres.2009.07.001
52. Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA, Caldwell RW, Caldwell RB (2005) Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol 167:599–607. doi:10.1016/S0002-9440(10)63001-5
53. Lo AC, Cheung AK, Hung VK, Yeung CM, He QY, Chiu JF, Chung SS, Chung SK (2007) Deletion of aldose reductase leads to protection against cerebral ischemic injury. J Cereb Blood Flow Metab 27:1496–1509. doi:10.1038/sj.jcbfm.9600452
54. Penn JS, Tolman BL, Bullard LE (1997) Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radic Biol Med 22:977–984
55. He T, Xing YQ, Zhao XH, Ai M (2007) Interaction between iNOS and COX-2 in hypoxia-induced retinal neovascularization in mice. Arch Med Res 38:807–815. doi:10.1016/j.arcmed.2007.05.003
56. Coombs JL, Van Der List D, Chalupa LM (2007) Morphological properties of mouse retinal ganglion cells during postnatal development. J Comp Neurol 503:803–814. doi:10.1002/cne.21429
57. Shao Z, Fu Z, Stahl A, Joyal JS, Hatton C, Juan A, Hurst C, Evans L, Cui Z, Pei D, Gong Y, Xu D, Tian K, Bogardus H, Edin ML, Lih F, Sapieha P, Chen J, Panigrahy D, Hellstrom A, Zeldin DC, Smith LE (2014) Cytochrome P450 2C8 omega3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization–brief report. Arterioscler Thromb Vasc Biol 34:581–586. doi:10.1161/ATVBAHA.113.302927
58. Fu Z, Lofqvist CA, Shao Z, Sun Y, Joyal JS, Hurst CG, Cui RZ, Evans LP, Tian K, SanGiovanni JP, Chen J, Ley D, Pupp IH, Hellstrom A, Smith LE (2015) Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose–endoplasmic reticulum stress reduction to increase adiponectin. Am J Clin Nutr 101(4):879–888. doi:10.3945/ajcn.114.099291
59. Li J, Liu CH, Sun Y, Gong Y, Fu Z, Evans LP, Tian KT, Juan AM, Hurst CG, Mammoto A, Chen J (2014) Endothelial TWIST1 promotes pathological ocular angiogenesis. Invest Ophthalmol Vis Sci 55:8267–8277. doi:10.1167/iovs.14-15623
60. Wang Z, Cheng R, Lee K, Tyagi P, Ding L, Kompella UB, Chen J, Xu X, Ma JX (2015) Nanoparticle-mediated expression of a wnt pathway inhibitor ameliorates ocular neovascularization. Arterioscler Thromb Vasc Biol 35:855–864. doi:10.1161/ATVBAHA.114.304627
61. Wang Z, Moran E, Ding L, Cheng R, Xu X, Ma JX (2014) PPARalpha regulates mobilization and homing of endothelial progenitor cells through the HIF-1alpha/SDF-1 pathway. Invest Ophthalmol Vis Sci 55:3820–3832. doi:10.1167/iovs.13-13396